Video

Data Show the Rate of Acquiring COVID-19 During Hospital Stay Is Significantly Lower Than Expected

Jeff Trinkl, MD, director of clinical informatics at Epic, and Caleb Cox, data scientist at Epic, explain that only about 1.8% of patients contracted COVID-19 during a hospital stay at the highest peak of cases in December 2020.

Pharmacy Times interviewed Jeff Trinkl, MD, director of clinical informatics at Epic, and Caleb Cox, data scientist at Epic, to discuss the results of a study that showed that despite a national reluctance to go to the hospital or emergency department due to concerns about contracting COVID-19, the rates of acquiring COVID-19 during a hospital stay were actually quite low, with only about 1.8% of patients contracting COVID-19 during their stay at the highest peak of cases in December 2020.

During the interview, Trinkl discussed the impetus for this study investigating the frequency with which patients developed COVID-19 while hospitalized, whether the research may have been impacted by patients who might have been positive on admission to the hospital but tested negative at that time due to a lower viral load, why the rate of patients developing COVID-19 while hospitalized might be so low, what the implications of these study results are on trends in hospital admissions, and whether hospitals would be able to handle increased admissions if patients begin to return to the hospital for non-COVID related appointments.

Related Videos
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
Pharmacy, Advocacy, Opioid Awareness Month | Image Credit: pikselstock - stock.adobe.com
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Hurricane Helene, Baxter plant, IV fluids shortage, health systems impact, injectable medicines, compounding solutions, patient care errors, clinical resources, operational consideration, fluid conservation, sterile water, temperature excursions, training considerations, patient safety, feedback request
Image Credit: © peopleimages.com - stock.adobe.com
Pharmacists, Education, Advocacy, Opioid Awareness Month | Image Credit: Jacob Lund - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards